ZENOTECH LABORATORIES
|
The Current P/E Ratio of ZENOTECH LABORATORIES is -257.02.
| Share Price | ₹45.2 | May 26,2026 |
| Market Cap | ₹275.8 Cr | |
| Earnings-TTM | ₹-1.1 Cr | TTM-Standalone Results |
| Price/Earnings | -257.02x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ZENOTECH LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹275.8 Cr] as on May 26,2026
(/) Earnings [ ₹-1.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -257.02x ]
Thus, for ZENOTECH LABORATORIES , the investors are currently willing to pay -257.02 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZENOTECH LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZENOTECH LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZENOTECH LABORATORIES
PE Ratio Performance Analysis for ZENOTECH LABORATORIES
- ZENOTECH LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 27.71x.
- ZENOTECH LABORATORIES 's operated at median p/e ratio of 24.79x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZENOTECH LABORATORIES 's p/e ratio peaked in Mar2025 at 56.45x.
- ZENOTECH LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does ZENOTECH LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ZENOTECH LABORATORIES | -1.07 | -257.02 | 275.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.19 | 441,610.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.81 | 179,279.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 70.46 | 150,649.0 |
| CIPLA LTD | 3,869.79 | 29.58 | 114,469.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.77 | 110,955.0 |
| MANKIND PHARMA LTD | 1,926.41 | 51.84 | 99,864.1 |
| LUPIN LTD | 5,355.47 | 19.33 | 103,507.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.60 | 108,568.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 24.05 | 84,220.9 |
| LAURUS LABS LTD | 889.85 | 83.35 | 74,165.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZENOTECH LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -257.02x |
| Max industry PE | 83.35x |
| Median industry PE | 29.58x |
| Average industry PE | 16.18x |
You may also like the below Video Courses